List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Others observations: Methyldopa is listed for use in the management of pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines. |
PAHO Strategic Fund Medicine List | 6.1. Antihypertensive medicines |
Others observations: Methyldopa is listed for use only in the management of pregnancy‐induced hypertension. Its use in the treatment of essential hypertension is not recommended in view of the evidence of greater efficacy and safety of other medicines (WHO 20th EML). |
Peru | 12.3 Anti-Hypertensives | No observations |
Chile | Essential and Prioritized Medications | No observations |
Colombia | 05.3 Anti-Hypertensives | No observations |
Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |
Cuba | 12.3 Antihipertensivos | No observations |
List | Section | Observation |
---|---|---|
Bolivia | LINAME 2011 - 2013 | No observations |
Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |